Archive · 24 Jul 2025
Pharma Industry Updates: Financials, Collaborations, and Acquisitions
Several pharmaceutical companies made significant announcements.
Dr. Reddy's Laboratories saw a slight profit increase due to rising revenue, even though prices fell in North America.
Apollo Hospitals and Siemens Healthineers are teaming up to improve liver disease care.
Biocon Biologics has a new head of brand communications.
Glenmark Pharmaceuticals got a warning from the US FDA for problems at its plant.
Lastly, Natco Pharma wants to buy a big part of a South African drug company.
Dr. Reddy's Laboratories' Q1 profit increased marginally due to revenue growth despite North American price erosion.
Apollo Hospitals and Siemens Healthineers are collaborating to advance liver healthcare.
Biocon Biologics appointed Deepali Naair as Global Head of Brand & Corporate Communications.
Glenmark Pharmaceuticals received a USFDA warning for manufacturing lapses at its Pithampur plant.
Natco Pharma offered to acquire a 36% stake in Adcock Ingram Holdings for up to Rs 2,100 crore.
- Who
- Dr. Reddy's Laboratories, Apollo Hospitals, Siemens Healthineers, Biocon Biologics, Glenmark Pharmaceuticals, Natco Pharma.
- What
- Various pharmaceutical companies announced financial results, collaborations, and acquisitions.
- When
- July 24, 2025 (published)
- Where
- India (Dr. Reddy's, Glenmark, Natco), North America, South Africa
- Why
- The reports cover company performance, strategic partnerships, regulatory issues, and acquisition plans within the pharmaceutical sector.
Company Performance and Outlook
Financial Developments and Strategic Initiatives
Dr. Reddy's Financial Performance
Company Performance and Outlook
Dr. Reddy's: The marginal profit growth, offset by the decline in revenue.
Financial Developments and Strategic Initiatives
Dr. Reddy's: The increase in revenue, reflecting overall growth.
Glenmark Plant Compliance
Company Performance and Outlook
Glenmark: Receiving a warning from the US FDA for manufacturing lapses.
Financial Developments and Strategic Initiatives
Glenmark: No positive view presented.
- Dr. Reddy's Q1 Profit
- Rs. 1,409 crore
- Dr. Reddy's Revenue Increase
- 11%
- Glenmark Plant Location
- Pithampur, Madhya Pradesh
- Natco Pharma Offer
- Acquire 36% of Adcock Ingram
- Natco Pharma offer value
- Rs 2,100 crore